Rising Prevalence of Nasopharyngeal Cancer is Expected to Boost the Market Growth

Published: Jun 2021

The global Nasopharyngeal Cancer market is anticipated to grow at a modest CAGR of around 2.6% during the forecast period (2021-2027). Nasopharyngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the nasopharynx, which is the upper part of the pharynx (throat) behind the nose. According to the American Institute for Cancer Research, it is the 23rd most common cancer worldwide, and in 2018, Brunei (9.9 in 100,000) had the highest rate of nasopharyngeal cancer geographically. The rising prevalence rates of nasopharyngeal cancer, the growing geriatric population, and the high consumption of tobacco and alcohol are the major factors that are driving the growth of the global nasopharyngeal cancer market. The main cause of the rising incidence of this cancer is the lack of awareness about this cancer and treatments among the common population. Moreover, according to the Health Protection Center, nasopharyngeal cancer is more common in the southern part of China than in Western countries. Furthermore, in 2018, NPC caused 295 deaths, which was 2% of the total cancer deaths according to the same. Whereas, the NPC is uncommon in the US, as per the American Society of Clinical Oncology (ASCO), in the US, less than 1 person out of 100,000 people is diagnosed with NPC each year. So it is expected that the market will grow in the Asia-Pacific region, especially in Southeast Asia (Thailand, Vietnam, Indonesia, Malaysia, and Singapore).

Browse the full report description of "Global Nasopharyngeal Cancer Market Size, Share & Trends Analysis Report By Cancer Type (Keratinising Squamous Cell Carcinoma, Non-Keratinising Squamous Cell Carcinoma, and Others), By Diagnosis Method (Initial Diagnosis and Advanced Diagnosis), By Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, and Others) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/nasopharyngeal-cancer-market

The high cost of nasopharyngeal cancer treatments is the factor that may hamper the growth of the market. The advancement in new technology and cost-effective treatments may be expected to increase market growth in upcoming years. Furthermore, government awareness programs and investments for R&D activities can create lucrative opportunities in the global nasopharyngeal cancer market during the forecast period.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Cancer Type

o By Diagnosis Method

o By Therapy

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- BioDiem Ltd, Biocon Limited, Bristol-Myers Squibb Co., Cyclacel Pharmaceuticals, Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, among others

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Nasopharyngeal Cancer Market Report Segment

By Cancer Type

  • Keratinising Squamous Cell Carcinoma
  • Non-Keratinising Squamous Cell Carcinoma
  • Undifferentiated Carcinomas
  • Other (Adenocarcinoma and Adenoid Cystic Carcinomas)

By Diagnosis Method

  • Initial Diagnosis

o Nasendoscopy

o Panendoscopy

o Fine Needle Aspiration/Needle Biopsy

  • Advanced Diagnosis

o CT Scan

o PET Scan

o MRI Scan

o Bone Scan

By Therapy

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery

Global Nasopharyngeal Cancer Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/nasopharyngeal-cancer-market